Vaginal Progesterone in Twin With Short Cervix

PHASE3CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

April 5, 2016

Primary Completion Date

September 1, 2018

Study Completion Date

December 28, 2019

Conditions
Preterm BirthTwin Dichorionic Diamniotic Placenta
Interventions
DRUG

Progesterone

"women will receive progesterone vaginal pesarries containing 200mg of progesterone twice daily . it will be used by the patient as one vaginal pessary per vagina twice per day .~women will be showed how to use tablets . medication will be started at 20 -24 weeks and stopped at 36+6 weeks"

OTHER

Placebo

women will receive placebo pessary twice a day. women will be showed how to use tablets . medication will be started at 20-24 weeks and stopped at 36+6 weeks

Trial Locations (1)

Unknown

Ain Shams University, Maternity Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02697331 - Vaginal Progesterone in Twin With Short Cervix | Biotech Hunter | Biotech Hunter